Han‐Chung Wu

9.7k total citations · 2 hit papers
169 papers, 7.1k citations indexed

About

Han‐Chung Wu is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Han‐Chung Wu has authored 169 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Molecular Biology, 34 papers in Oncology and 32 papers in Infectious Diseases. Recurrent topics in Han‐Chung Wu's work include Monoclonal and Polyclonal Antibodies Research (25 papers), Mosquito-borne diseases and control (22 papers) and Glycosylation and Glycoproteins Research (16 papers). Han‐Chung Wu is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (25 papers), Mosquito-borne diseases and control (22 papers) and Glycosylation and Glycoproteins Research (16 papers). Han‐Chung Wu collaborates with scholars based in Taiwan, United States and China. Han‐Chung Wu's co-authors include Ruei‐Min Lu, I-Ju Liu, Hsin‐Jung Li, Chi‐Chiu Lee, Chin‐Tarng Lin, De-Kuan Chang, Chien‐Hsun Wu, Yi‐Ping Wang, Kang-Hao Liang and Albert Lo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Han‐Chung Wu

162 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Development of therapeutic antibodies for the treatment of diseases

2020 1.4k citations Ruei‐Min Lu, I-Ju Liu et al. profile →
Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection

2022 157 citations Ruei‐Min Lu, Shih-Han Ko et al. profile →

Peers

Countries citing papers authored by Han‐Chung Wu

Since Specialization

Citations

This map shows the geographic impact of Han‐Chung Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han‐Chung Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han‐Chung Wu more than expected).

Fields of papers citing papers by Han‐Chung Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han‐Chung Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han‐Chung Wu. The network helps show where Han‐Chung Wu may publish in the future.

Co-authorship network of co-authors of Han‐Chung Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Han‐Chung Wu. A scholar is included among the top collaborators of Han‐Chung Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han‐Chung Wu. Han‐Chung Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluating AI Chatbot Responses to Postkidney Transplant Inquiries 2025 ·Transplantation Proceedings ·(unknown), Xutao Chen, (unknown), (unknown), Muhammad Usman, Zhizhang Chen, Han‐Chung Wu, Junjian Huang, (unknown)	3
2	Developing a delivery strategy for combined drug treatment with multi-targeting immunoliposomes 2024 ·Journal of Drug Delivery Science and Technology ·Monika Kumari, (unknown), Feng-Yi Ke, Peter H. Pan, (unknown), (unknown), Han‐Chung Wu	2
3	Arginine Methylation of DDX3 by PRMT1 Mediates Mitochondrial Homeostasis to Promote Breast Cancer Metastasis 2024 ·Cancer Research ·(unknown), (unknown), (unknown), Yu‐Chu Chang, (unknown), (unknown), I‐Lin Tsai, (unknown), Han‐Chung Wu, Ching‐Chieh Yang, Chi‐Ching Lee, Cheng‐Wei Lin	13
4	Succinate Is a Natural Suppressor of Antiviral Immune Response by Targeting MAVS 2022 ·Frontiers in Immunology ·Yue Xiao, (unknown), (unknown), Jiazheng Quan, Xibao Zhao, Haimei Tang, Han‐Chung Wu, Qianqian Di, Zherui Wu, Weilin Chen	22
5	ENO1 Promotes Lung Cancer Metastasis via HGFR and WNT Signaling–Driven Epithelial-to-Mesenchymal Transition 2021 ·Cancer Research ·Hsin‐Jung Li, Feng-Yi Ke, Chia-Ching Lin, (unknown), (unknown), Yi‐Ping Wang, Kang-Hao Liang, (unknown), Ya‐Hsuan Chang, Hsuan‐Yu Chen, Pan‐Chyr Yang, Han‐Chung Wu	101
6	Monoclonal Antibodies against Nucleocapsid Protein of SARS-CoV-2 Variants for Detection of COVID-19 2021 ·International Journal of Molecular Sciences ·Ruei‐Min Lu, Shih-Han Ko, Chen Wy, Yu‐Ling Chang, Hsiu-Ting Lin, Han‐Chung Wu	18
7	Homogeneous antibody and CAR-T cells with improved effector functions targeting SSEA-4 glycan on pancreatic cancer 2021 ·Proceedings of the National Academy of Sciences ·Chih-Wei Lin, (unknown), (unknown), Tsui-Ling Hsu, (unknown), Han‐Chung Wu, Chia‐Ning Shen, Van Duc Dang, Mingwei Chen, (unknown), Chi‐Huey Wong	27
8	Reversal of pancreatic desmoplasia by a tumour stroma-targeted nitric oxide nanogel overcomes TRAIL resistance in pancreatic tumours 2021 ·Gut ·Hsi‐Chien Huang, Yun‐Chieh Sung, Chung‐Pin Li, Dehui Wan, Po‐Han Chao, Yu‐Ting Tseng, (unknown), Hui‐Teng Cheng, Fu‐Fei Hsu, Chieh‐Cheng Huang, Yi‐Ting Chen, (unknown), Yuhui Liao, (unknown), Yu‐Chuan Shih, I-Ju Liu, Han‐Chung Wu, Tsai‐Te Lu, Jane Wang, Yunching Chen	39
9	EpCAM Signaling Promotes Tumor Progression and Protein Stability of PD-L1 through the EGFR Pathway 2020 ·Cancer Research ·(unknown), Kang-Hao Liang, (unknown), (unknown), Mei‐Ying Liao, (unknown), Yi‐Ting Chuang, (unknown), (unknown), Han‐Chung Wu	54
10	Small G protein signalling modulator 2 (SGSM2) is involved in oestrogen receptor-positive breast cancer metastasis through enhancement of migratory cell adhesion via interaction with E-cadherin 2019 ·Cell Adhesion & Migration ·(unknown), (unknown), Han‐Chung Wu, Chih‐Hsiung Wu, Li-Ching Chen, Chi‐Cheng Huang, (unknown), Tzu-Chun Cheng, Hui-Wen Chang, Chi‐Tang Ho, Shih‐Hsin Tu, Yuan‐Soon Ho	10
11	Epitope resurfacing on dengue virus-like particle vaccine preparation to induce broad neutralizing antibody 2018 ·eLife ·(unknown), (unknown), Jyung‐Hurng Liu, (unknown), (unknown), (unknown), Han‐Chung Wu, (unknown), Yi‐Ling Lin, (unknown), Gwong‐Jen J. Chang, (unknown), (unknown), Day‐Yu Chao	28
12	Minocycline suppresses dengue virus replication by down-regulation of macrophage migration inhibitory factor-induced autophagy 2018 ·Antiviral Research ·Yen‐Chung Lai, Yung‐Chun Chuang, Chih‐Peng Chang, Yee-Shin Lin, Guey‐Chuen Perng, Han‐Chung Wu, Shie‐Liang Hsieh, Trai‐Ming Yeh	16
13	EpEX/EpCAM and Oct4 or Klf4 alone are sufficient to generate induced pluripotent stem cells through STAT3 and HIF2α 2017 ·Scientific Reports ·(unknown), Kang-Hao Liang, Yi‐Ping Wang, (unknown), Yaa‐Jyuhn James Meir, Sareina Chiung‐Yuan Wu, (unknown), Jean Lu, Han‐Chung Wu	39
14	Generation of Monoclonal Antibodies against Dengue Virus Type 4 and Identification of Enhancing Epitopes on Envelope Protein 2015 ·PLoS ONE ·(unknown), Mei‐Ying Liao, Chien‐Yu Chiu, (unknown), (unknown), (unknown), Gwong‐Jen J. Chang, Han‐Chung Wu	8
15	Effects of the music therapy on the serotonin and tubulin in brain tissue of chronic unpredictable mild stress rats 2014 ·Zhonghua xingwei yixue yu naokexue zazhi ·Han‐Chung Wu	1
16	Analysis of Epitopes on Dengue Virus Envelope Protein Recognized by Monoclonal Antibodies and Polyclonal Human Sera by a High Throughput Assay 2012 ·PLoS neglected tropical diseases ·(unknown), Wen-Yang Tsai, I-Ju Liu, Pi‐Chun Li, Mei‐Ying Liao, Jih‐Jin Tsai, Yi-Chieh Wu, Chih-Yun Lai, Chih‐Hsuan Lu, Jyh-Hsiung Huang, Gwong‐Jen J. Chang, Han‐Chung Wu, Wei‐Kung Wang	59
17	Attenuation of enoyl coenzyme A hydratase 1 expression in colorectal cancer cells using small interfering RNA inhibits cell proliferation and migration 2012 ·Molecular Medicine Reports ·(unknown), Fei Kuang, Han‐Chung Wu, Yuhao Zhang	6
18	Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II 2008 ·Journal of Virology ·Chih-Yun Lai, Wen-Yang Tsai, Su-Ru Lin, Chuan‐Liang Kao, (unknown), Chwan‐Chuen King, Han‐Chung Wu, Gwong‐Jen J. Chang, Wei‐Kung Wang	242
19	Hepatocellular carcinoma cell-specific peptide ligand for targeted drug delivery 2008 ·Cancer Research ·Albert Lo, Chin‐Tarng Lin, Han‐Chung Wu	4
20	Peptide-Mediated Targeting to Tumor Blood Vessels of Lung Cancer for Drug Delivery 2007 ·Cancer Research ·(unknown), Chin‐Tarng Lin, (unknown), De-Kuan Chang, Han‐Chung Wu	123

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact